# A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

> **NCT05566249** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Rectal Cancer
- Rectosigmoid Cancer
- Rectosigmoid Junction Cancer

## Interventions

- **DEVICE:** ArtiSential

## Key facts

- **NCT ID:** NCT05566249
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566249, "A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05566249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*